Rapid Fire Poster

231 - Rapid Fire Poster Session: Vaccines

Presentations:

• 12:15 PM - 12:20 PM

  1976 - Accounting for Vaccination History in Estimates of Current Season Vaccine Effectiveness in the US Flu VE Network, 2012-13 through 2017-18
  Sara S. Kim, MPH – ORISE; US Centers for Disease Control and Prevention; Ivo Foppa, ScD – Battelle; Centers for Disease Control and Prevention; Jessie R. Chung, MPH – Centers for Disease Control and Prevention; Edward Belongia, MD – Marshfield Clinic Research Institute; Huong McLean, PhD, MPH – Marshfield Clinic Research Institute; Arnold Monto, MD – University of Michigan; Joshua G. Petrie, PhD, MPH – University of Michigan; Richard K. Zimmerman, MA;MD;MPH;MS – University of Pittsburgh; Mary Patricia Nowalk, PhD – University of Pittsburgh; Manjusha Gaglani, MBBS – Baylor Scott & White Health; Kempapura Murthy, MBBS, MPH – Baylor Scott & White Health; Michael L. Jackson, PhD – Kaiser Permanente Washington; Brendan Flannery, PhD – Centers for Disease Control and Prevention; Manish Patel, MD – Centers for Disease Control and Prevention
• 12:20 PM - 12:25 PM

  1975 - Immunogenicity of Inactivated Influenza Vaccines Given Early versus Late after Pediatric Allogeneic Hematopoietic Cell Transplantation
  Jennifer E. Schuster, MD – Children's Mercy Hospital; Andrew Speaker, PhD – Vanderbilt University Medical Center; Lubna Hamdan, MD – Vanderbilt University Medical Center; Einas Batarseh, MD – Vanderbilt University Medical Center; Laura S. Stewart, PhD – Vanderbilt University Medical Center; Daniel Dulek, MD – Vanderbilt University Medical Center; Carrie L. Kitko, MD – Vanderbilt University Medical Center; Flor M. Munoz, MD – Baylor College of Medicine; Claire Bocchini, MD – Baylor College of Medicine; Lara Danziger-Isakov, MD, MPH – Cincinnati Children's Hospital Medical Center; Michael Grimley, MD – Cincinnati Children's Hospital Medical Center; Rakesh Goyal, MD, MRCP – Children's Mercy Hospital; Susan E. Coffin, MD, MPH – Children's Hospital of Philadelphia; Jason L. Freedman, MD, MSCE – Perelman School of Medicine at the University of Pennsylvania; Janet A. Englund, MD – Seattle Children's Hospital/Univ. of Washington; Paul A. Carpenter, MB. BS., BSc. (Med) – Fred Hutchinson Cancer Research Center; University of Washington; Monica I. Ardura, DO, MSCS – Nationwide Children's Hospital; Jeffrey Auletta, MD – The Ohio State University; Rachel Wattier, MD, MHS – University of California, San Francisco; Kenny Truong, BSN – University of California, San Francisco; Gabriela Maron, MD – St. Jude Children's Research Hospital; Kim J. Allison, RN – St. Jude Children's Research Hospital; Natasha B. Halasa, MD, MPH – Vanderbilt University Medical Center
• 12:25 PM - 12:30 PM

  1974 - Meningococcal Vaccination among Patients Newly Diagnosed at High-Risk for Meningococcal Disease in the US
  Lindsay Bengtson, PhD, MPH – Optum; Gary S. Marshall, MD – University of Louisville; Ami R. Buikema, MPH – Optum; Eleena Koep, MS – Optum; Patricia Novy, PhD – GSK; Cosmina Hogea, PhD – GSK
• 12:35 PM - 12:40 PM

  1972 - A Cohort Analysis of Completion of the Pediatric Measles-Mumps-Rubella-Varicella Series in the United States
  Lara J. Wolfson, PhD – Merck & Co., Inc.; Mawuli K. Nyaku, DrPh – Merck & Co., Inc.; Shikha Surati, MPH – Merck & Co., Inc.; Zhiwen Liu, PhD – Merck & Co., Inc.; Manjiri D. Pawaskar, PhD – Merck & Co., Inc.
• 12:40 PM - 12:45 PM

  1973 - Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink
  Kayla E. Hanson, MPH – Marshfield Clinic Research Institute; Huong McLean, PhD, MPH – Marshfield Clinic Research Institute; Mona Marin, MD – Centers for Disease Control and Prevention; Lakshmi Panagiotakopoulos, MD, MPH – Centers for Disease Control and Prevention; Eric Weintraub, MPH – Centers for Disease Control and Prevention; Matthew F. Daley, MD – Kaiser Permanente Colorado; Holly Groom, MPH – Kaiser Permanente Northwest; Lisa Jackson, MD, MPH – Kaiser Permanente Washington Health Research Institute; Steven J. Jacobsen, MD, PhD – Kaiser Permanente Southern California; Nicola Klein, MD, PhD – Kaiser Permanente Northern California; James D. Nordin, MD, MPH – HealthPartners Institute; Edward Belongia, MD – Marshfield Clinic Research Institute

Co-Author(s)

• LB

  Lindsay Bengtson, PhD, MPH

  Associate Director
  Optum
  Eden Prairie, MN

  Disclosure: GlaxoSmithKline : Other Financial or Material Support, I am an employee of Optum which was contracted by GlaxoSmithKline to conduct this research.
  Optum: Employee
• LW

  Lara Wolfson, PhD

  Executive Director
  Merck & Co., Inc.
  Kenilworth, NJ

  Disclosure: Merck: Employee
• IF

  Ivo Foppa, ScD

  Sr. Research Scientist
  Battelle; Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• GM

  Gary Marshall, MD

  Professor of Pediatrics
  University of Louisville
  Louisville, KY

  Disclosure: GlaxoSmithKline: Consultant, Scientific Research Study Investigator
  Merck: Consultant, Scientific Research Study Investigator
  Pfizer: Consultant, Scientific Research Study Investigator, Speaker's Bureau
  Sanofi Pasteur: Consultant, Scientific Research Study Investigator, Speaker's Bureau
  Seqirus: Consultant, Scientific Research Study Investigator
• HM

  Huong McLean, PhD, MPH

  Research Scientist
  Marshfield Clinic Research Institute
  Marshfield, WI

  Disclosure: Seqirus Inc: Grant/Research Support, Research Grant or Support
• MN

  Mawuli Nyaku, DrPh

  Director
  Merck & Co., Inc.
  Kenilworth, NJ

  Disclosure: Merck & Co., Inc.: Employee
• AS

  Andrew Speaker, PhD

  Assistant Professor of Biostatistics
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose
• AB

  Ami Buikema, MPH

  Senior Director, Respiratory and Infectious diseases
  Optum
  Eden Prairie, MN

  Disclosure: Optum: Employee
  Optum: Other Financial or Material Support, I am an employee of Optum which was contracted to conduct this research
• JC

  Jessie Chung, MPH

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• LH

  Lubna Hamdan, MD

  Postdoctoral Fellow
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose
• MM

  Mona Marin, MD

  Medical Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• SS

  Shikha Surati, MPH

  Specialist
  Merck & Co., Inc.
  Kenilworth, NJ

  Disclosure: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA: Employee, Shareholder
• EB

  Einas Batarseh, MD

  Postdoctoral Research Fellow
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose
• EB

  Edward Belongia, MD

  Director, Center for Clinical Epidemiology & Population Health
  Marshfield Clinic Research Institute
  Marshfield, WI

  Disclosure: Nothing to disclose
• EK

  Eleena Koep, MS

  Senior Research Analyst
  Optum
  Eden Prairie, MN

  Disclosure: GlaxoSmithKline: Grant/Research Support
  Optum: Employee
• ZL

  Zhiwen Liu, PhD

  Director
  Merck & Co., Inc.
  Kenilworth, New Jersey

  Disclosure: Merck: Employee
• LP

  Lakshmi Panagiotakopoulos, MD, MPH

  Medical Officer
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• HM

  Huong McLean, PhD, MPH

  Research Scientist
  Marshfield Clinic Research Institute
  Marshfield, WI

  Disclosure: Seqirus Inc: Grant/Research Support, Research Grant or Support
• PN

  Patricia Novy, PhD

  US Medical Affairs Lead, Meningococcal Vaccines
  GSK
  Philadelphia, Pennsylvania

  Disclosure: GSK: Employee, Shareholder
• LS

  Laura Stewart, PhD

  Research Coordinator
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose
• EW

  Eric Weintraub, MPH

  Epidemiologist
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• MD

  Matthew Daley, MD

  Senior Investigator
  Kaiser Permanente Colorado
  Aurora, Colorado

  Disclosure: Nothing to disclose
• DD

  Daniel Dulek, MD

  Assistant Professor
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose
• AM

  Arnold Monto, MD

  Professor of Epidemiology, Global Public Health; Thomas Francis, Jr. Collegiate Professor of Public Health
  University of Michigan
  Ann Arbor, MI

  Disclosure: Sanofi Pasteur: Other Financial or Material Support
  Seqirus: Other Financial or Material Support
• HG

  Holly Groom, MPH

  Research Associate
  Kaiser Permanente Northwest
  Portland, OR

  Disclosure: Nothing to disclose
• CK

  Carrie Kitko, MD

  Dr
  Vanderbilt University Medical Center
  Nashville, TN

  Disclosure: Nothing to disclose
• JP

  Joshua Petrie, PhD, MPH

  Research Investigator
  University of Michigan
  Ann Arbor, MI

  Disclosure: Nothing to disclose
• LJ

  Lisa Jackson, MD, MPH

  Senior Investigator
  Kaiser Permanente Washington Health Research Institute
  Seattle, Washington

  Disclosure: Nothing to disclose
• 

  Flor Munoz, MD

  Associate Professor of Pediatrics
  Baylor College of Medicine
  Houston, TX

  Disclosure: Biocryst: Grant/Research Support
  CDC: Research Grant
  Moderna: Other Financial or Material Support, Safety Monitoring Board Member/Chair
  NIH: Research Grant
  Novavax: Research Grant
  UP to Date: Author and Editor - Royalties, Other Financial or Material Support
• RZ

  Richard Zimmerman, MA;MD;MPH;MS

  Dr
  University of Pittsburgh
  Pittsburgh, PA

  Disclosure: Sanofi Pasteur: Grant/Research Support
• CB

  Claire Bocchini, MD

  Assistant Professor of Pediatrics
  Baylor College of Medicine
  Houston, TX

  Disclosure: Nothing to disclose
• SJ

  Steven Jacobsen, MD, PhD

  Senior Director of Research
  Kaiser Permanente Southern California
  Pasadena, CA

  Disclosure: Nothing to disclose
• MN

  Mary Patricia Nowalk, PhD

  Investigator
  University of Pittsburgh
  Pittsburgh, PA

  Disclosure: Merck & Co., Inc.: Grant/Research Support
  Pfizer, Inc.: Grant/Research Support
• 

  Lara Danziger-Isakov, MD, MPH

  Professor of Pediatrics
  Cincinnati Children's Hospital Medical Center
  Cincinnati, Ohio

  Disclosure: Ansun: Research Grant
  Astellas: Grant/Research Support
  GlaxoSmithKline: Advisory Board
  Merck: Consultant, Grant/Research Support
  Shire: Grant/Research Support
  Viracor: Grant/Research Support
• MG

  Manjusha Gaglani, MBBS

  Director, Center for Research in Vaccines and Infections (CRVI); Josephine Ballard Endowed Research Chair and Professor of Pediatrics; Chief, Pediatric Infectious Diseases
  Baylor Scott & White Health
  Temple, TX

  Disclosure: Janssen (Johnson & Johnson): Other Financial or Material Support
  Medimmune/AstraZeneca: Other Financial or Material Support
• NK

  Nicola Klein, MD, PhD

  Director, Kaiser Permanente Vaccine Study Center and Senior Research Scientist
  Kaiser Permanente Northern California
  Oakland, CA

  Disclosure: GlaxoSmithKline: Grant/Research Support
  Merck & Co: Grant/Research Support
  Pfizer: Grant/Research Support
  Protein Science (now Sanofi Pasteur): Grant/Research Support
  Sanofi Pasteur: Grant/Research Support
• MG

  Michael Grimley, MD

  Associate Professor of Clinical Pediatrics
  Cincinnati Children's Hospital Medical Center
  Cincinnati, OH

  Disclosure: Nothing to disclose
• KM

  Kempapura Murthy, MBBS, MPH

  Research SAS Programmer
  Baylor Scott & White Health
  Temple, TX

  Disclosure: Nothing to disclose
• JN

  James Nordin, MD, MPH

  Clinical Investigator
  HealthPartners Institute
  Minneapolis, MN

  Disclosure: Nothing to disclose
• EB

  Edward Belongia, MD

  Director, Center for Clinical Epidemiology & Population Health
  Marshfield Clinic Research Institute
  Marshfield, WI

  Disclosure: Nothing to disclose
• RG

  Rakesh Goyal, MD, MRCP

  Chief BMT and Professor of Pediatrics
  Children's Mercy Hospital
  Kansas City, MO

  Disclosure: Nothing to disclose
• MJ

  Michael Jackson, PhD

  Associate Scientific Investigator
  Kaiser Permanente Washington
  Seattle, WA

  Disclosure: Nothing to disclose
• SC

  Susan Coffin, MD, MPH

  Dr
  Children's Hospital of Philadelphia
  Philadelphia, Pennsylvania

  Disclosure: Merck: Member of DSMB
• BF

  Brendan Flannery, PhD

  US Flu VE Network PI at CDC
  Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• JF

  Jason Freedman, MD, MSCE

  Assistant Professor of Clinical Pediatrics
  Perelman School of Medicine at the University of Pennsylvania
  Philadelphia, PA

  Disclosure: Massive Bio: Consultant
• MP

  Manish Patel, MD

  Medical Officer
  Centers for Disease Control and Prevention
  Atlanta, Georgia

  Disclosure: Nothing to disclose
• 

  Janet Englund, MD

  Professor
  Seattle Children's Hospital/Univ. of Washington
  Seattle, Washington

  Disclosure: AstraZeneca: Grant/Research Support
  Chimerix: Grant/Research Support
  GlaxoSmithKline: Consultant, Grant/Research Support
  Meissa Vaccines: Consultant
  Merck: Grant/Research Support
  Novavax: Grant/Research Support
  Sanofi Pasteur: Consultant
• PC

  Paul Carpenter, MB. BS., BSc. (Med)

  Full Member
  Fred Hutchinson Cancer Research Center; University of Washington
  Seattle, Washington

  Disclosure: Nothing to disclose
• MA

  Monica Ardura, DO, MSCS

  Associate Professor of Pediatrics
  Nationwide Children's Hospital
  Columbus, Ohio

  Disclosure: Shire: Grant/Research Support
• JA

  Jeffrey Auletta, MD

  Professor
  The Ohio State University
  Columbus, OH

  Disclosure: Nothing to disclose
• RW

  Rachel Wattier, MD, MHS

  Assistant Professor
  University of California, San Francisco
  San Francisco, CA

  Disclosure: Nothing to disclose
• KT

  Kenny Truong, BSN

  Research Nurse
  University of California, San Francisco
  San Francisco, CA

  Disclosure: Nothing to disclose
• GM

  Gabriela Maron, MD

  Assistant Member
  St. Jude Children's Research Hospital
  Memphis, Tennessee

  Disclosure: Nothing to disclose
• KA

  Kim Allison, RN

  Manager Clinical Research Operations
  St. Jude Children's Research Hospital
  Memphis, TN

  Disclosure: Nothing to disclose
• 

  Natasha Halasa, MD, MPH

  Associate Professor
  Vanderbilt University Medical Center
  Nashville, Tennessee

  Disclosure: Moderna: Consultant
  Sanofi Pasteur: Grant/Research Support, vaccine and HAI testing

Moderator(s)

• 

  Kathryn Edwards, MD

  Professor of Pediatrics
  Vanderbilt University Medical Center
  Nashville, Tennessee

  Disclosure: Bionet: Consultant
  GlaxoSmithKline: Advisory Board
  IBM: Consultant
  Roche: member of DSMB, Other Financial or Material Support
  Sanofi Pasteur: member DSMB, Other Financial or Material Support
  Sequiras: Member DSMB, Other Financial or Material Support
  X4 Pharmaceuticals: Consultant

Presenting Author(s)

• KH

  Kayla Hanson, MPH

  Epidemiologist
  Marshfield Clinic Research Institute
  Marshfield, WI

  Disclosure: Nothing to disclose
• SK

  Sara Kim, MPH

  Project Coordinator
  ORISE; US Centers for Disease Control and Prevention
  Atlanta, GA

  Disclosure: Nothing to disclose
• 

  Jennifer Schuster, MD

  Assistant Professor
  Children's Mercy Hospital
  Kansas City, Missouri

  Disclosure: Merck, Sharpe, and Dohme: Research Grant
• MP

  Manjiri Pawaskar, PhD

  Director
  Merck & Co., Inc.
  Kenilworth, NJ

  Disclosure: Merck & Co., Inc.: Employee, Shareholder
• CH

  Cosmina Hogea, PhD

  Director
  GSK
  Philadelphia, Pennsylvania

  Disclosure: GlaxoSmithKline Vaccines: Employee, Shareholder